10:00am
to
11:30am |
|
Academia-based Translational Research and Industry Collaboration
(Seminar/Conference)
Salim Shah, Chief Scientist, Office of Operations and Planning, Georgetown University
A recent analysis by the Center for Medicines Research found that the failure rate for drugs in Phase II and III clinical trials has been rising and that the success rate for drugs in Phase II is dismally low. These failures are further accentuated by the finding that more than 50% of academia-published results are not reproducible and often fail in clinical drug development.
Conversely, treatment for disease such as for neurological disorders and cancer has not changed for decades, and the demand for newer technologies, targets, and drugs is greater than ever.
To solve these problems, academia-industry relationships have emerged as a "rescuer-in-chief," and institutions like ICTAS and the newly formed center at the National Institutes of Health--the National Center for Advancing Translational Sciences (NCATS)--are perfectly poised to make a difference and to shift the current paradigm to newer models where research and discovery become a joint effort between laboratory investigations and market demands.
Dr. Shah's seminar will provide a comparative analysis of the current practices of academia and of the differing roles that industry plays. In addition, the seminar will offer suggestions for recasting this relationship to reduce attrition rates in technology development. The seminar will also highlight the fundamental elements of an academia-industry relationship that are unique yet complement each other.
More information...
|
540-231-1929